Neuraxis, Inc. (NRXS) earnings · rev $3.6M
These earnings events as JSON? API free 100/dayNeuraxis, Inc. (NRXS) is a biotechnology company listed on AMEX.
This NRXS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported NRXS revenue for 2025-12-31 was $3.6M. Net income was -$7.8M. Revenue was up 32.9% from 2024-12-31 to 2025-12-31. NRXS currently screens at market cap $83.1M.
When the next NRXS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 32.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full NRXS research stays on the stock page; the tape stays on the quote page.
NRXS earnings FAQ
What are NRXS's latest revenue and net income?
Latest cached Neuraxis, Inc. (NRXS) revenue for Dec 31, 2025 was $3.6M. Net income was -$7.8M. Statements: https://lician.com/financials/nrxs
What is NRXS's latest diluted EPS?
Latest cached Neuraxis, Inc. (NRXS) diluted EPS for Dec 31, 2025 was -$0.95.
What period does the latest NRXS earnings print cover?
The latest cached Neuraxis, Inc. (NRXS) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did NRXS revenue change from the prior cached period?
Cached Neuraxis, Inc. (NRXS) revenue was up 32.9% from $2.7M (Dec 31, 2024) to $3.6M (Dec 31, 2025). Statements: https://lician.com/financials/nrxs
Where are NRXS earnings listed?
Cached earnings facts for Neuraxis, Inc. (NRXS) are listed at https://lician.com/earnings/nrxs. Statements: https://lician.com/financials/nrxs
Not investment advice.